Literature DB >> 25225716

Pulmonary vasodilator therapy and early postoperative outcome after modified Fontan operation.

Alberto Mendoza1, Leticia Albert1, Sylvia Belda2, Lidia Casanueva2, Dolores Herrera1, Miguel A Granados1, José M Velasco1, Enrique García1, Juan M Aguilar1, Juan V Comas1.   

Abstract

Although mortality is low after the modified Fontan procedure, there is a significant percentage of patients with prolonged postoperative recovery. The objective of this study is to evaluate the usefulness of postoperative administration of oral sildenafil and inhaled nitric oxide on early postoperative outcome. A prospective interventional and comparison study with a historical cohort was conducted. Between January, 2010 and March, 2013, 16 patients received oral sildenafil during immediate modified Fontan postoperative period. Inhaled nitric oxide was also administered if the patient was kept intubated 12 hours after surgery. Early postoperative outcome was compared with a historical cohort of 32 patients on whom the modified Fontan procedure was performed between March, 2000 and December, 2009. Postoperative administration of sildenafil and nitric oxide had no influence on early postoperative outcome after the modified Fontan procedure in terms of duration of pleural effusions, mechanical ventilation time, length of stay in the ICU, and length of hospital stay.

Entities:  

Keywords:  CHD; Modified Fontan operation; inhaled nitric oxide; pulmonary vasodilators; sildenafil

Mesh:

Substances:

Year:  2014        PMID: 25225716     DOI: 10.1017/S1047951114001772

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  2 in total

1.  Routine Sildenafil Does Not Improve Clinical Outcomes After Fontan Operation.

Authors:  J Leslie Gaddis Collins; Mark A Law; Santiago Borasino; W Clinton Erwin; David C Cleveland; Jeffrey A Alten
Journal:  Pediatr Cardiol       Date:  2017-09-07       Impact factor: 1.655

2.  Pulmonary vasodilator therapy as treatment for patients with a Fontan circulation: the Emperor's new clothes?

Authors:  Floris-Jan S Ridderbos; Quint A J Hagdorn; Rolf M F Berger
Journal:  Pulm Circ       Date:  2018-10-19       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.